The post China’s fintech ambitions drive interest in Venom Blockchain appeared on BitcoinEthereumNews.com. Reports from Toutiao indicate that a leading Chinese fintech company is in discussions to acquire blockchain technology from the Venom Foundation. While details of the negotiations remain confidential, sources suggest the goal is to integrate Venom’s infrastructure into financial services that support the real economy, from supply chain finance to cross-border settlements. The talks echo a familiar pattern. Chinese companies have a track record of moving into blockchain and digital asset sectors through bold acquisitions or strategic pivots, triggering market reactions. One notable case came from the crypto exchange Huobi, which pursued a strategy of overseas acquisitions starting in 2018, buying licenses and platforms in Japan and Singapore after Beijing tightened domestic regulation. The strategy enabled Huobi to maintain a global presence despite restrictions at home, though it also underlined how Chinese players often rely on foreign partnerships to keep pace with global innovation. Venom employs dynamic sharding to handle high transaction volumes and bottlenecks, a fair-ordering layer to address market manipulation issues, and cross-chain interoperability with Ethereum Virtual Machine (EVM) and Web Assembly (WASM).  However, analysts note that supply chain finance would benefit the most from Venom’s blockchain-based data credit system. Potential applications are wide-ranging. Supply chain finance has long been a bottleneck for small and medium-sized enterprises, where banks hesitate to extend credit due to limited data. Blockchain could help build a transparent “data credit” system to reduce that gap. For investors, the possible Venom deal raises familiar questions. Could it mirror Huobi’s experience, where overseas acquisitions became the foundation for long-term strategy despite regulatory headwinds? The negotiations are expected to extend into late 2025 or early 2026. Regardless of the outcome, the story reflects a broader structural shift: blockchain is steadily moving into the infrastructure layer of China’s financial system. Featured image via Shutterstock Source: https://finbold.com/chinas-fintech-ambitions-drive-interest-in-venom-blockchain/The post China’s fintech ambitions drive interest in Venom Blockchain appeared on BitcoinEthereumNews.com. Reports from Toutiao indicate that a leading Chinese fintech company is in discussions to acquire blockchain technology from the Venom Foundation. While details of the negotiations remain confidential, sources suggest the goal is to integrate Venom’s infrastructure into financial services that support the real economy, from supply chain finance to cross-border settlements. The talks echo a familiar pattern. Chinese companies have a track record of moving into blockchain and digital asset sectors through bold acquisitions or strategic pivots, triggering market reactions. One notable case came from the crypto exchange Huobi, which pursued a strategy of overseas acquisitions starting in 2018, buying licenses and platforms in Japan and Singapore after Beijing tightened domestic regulation. The strategy enabled Huobi to maintain a global presence despite restrictions at home, though it also underlined how Chinese players often rely on foreign partnerships to keep pace with global innovation. Venom employs dynamic sharding to handle high transaction volumes and bottlenecks, a fair-ordering layer to address market manipulation issues, and cross-chain interoperability with Ethereum Virtual Machine (EVM) and Web Assembly (WASM).  However, analysts note that supply chain finance would benefit the most from Venom’s blockchain-based data credit system. Potential applications are wide-ranging. Supply chain finance has long been a bottleneck for small and medium-sized enterprises, where banks hesitate to extend credit due to limited data. Blockchain could help build a transparent “data credit” system to reduce that gap. For investors, the possible Venom deal raises familiar questions. Could it mirror Huobi’s experience, where overseas acquisitions became the foundation for long-term strategy despite regulatory headwinds? The negotiations are expected to extend into late 2025 or early 2026. Regardless of the outcome, the story reflects a broader structural shift: blockchain is steadily moving into the infrastructure layer of China’s financial system. Featured image via Shutterstock Source: https://finbold.com/chinas-fintech-ambitions-drive-interest-in-venom-blockchain/

China’s fintech ambitions drive interest in Venom Blockchain

2025/09/09 22:10
2분 읽기
이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 crypto.news@mexc.com으로 연락주시기 바랍니다

Reports from Toutiao indicate that a leading Chinese fintech company is in discussions to acquire blockchain technology from the Venom Foundation. While details of the negotiations remain confidential, sources suggest the goal is to integrate Venom’s infrastructure into financial services that support the real economy, from supply chain finance to cross-border settlements.

The talks echo a familiar pattern. Chinese companies have a track record of moving into blockchain and digital asset sectors through bold acquisitions or strategic pivots, triggering market reactions.

One notable case came from the crypto exchange Huobi, which pursued a strategy of overseas acquisitions starting in 2018, buying licenses and platforms in Japan and Singapore after Beijing tightened domestic regulation. The strategy enabled Huobi to maintain a global presence despite restrictions at home, though it also underlined how Chinese players often rely on foreign partnerships to keep pace with global innovation.

Venom employs dynamic sharding to handle high transaction volumes and bottlenecks, a fair-ordering layer to address market manipulation issues, and cross-chain interoperability with Ethereum Virtual Machine (EVM) and Web Assembly (WASM). 

However, analysts note that supply chain finance would benefit the most from Venom’s blockchain-based data credit system. Potential applications are wide-ranging. Supply chain finance has long been a bottleneck for small and medium-sized enterprises, where banks hesitate to extend credit due to limited data. Blockchain could help build a transparent “data credit” system to reduce that gap.

For investors, the possible Venom deal raises familiar questions. Could it mirror Huobi’s experience, where overseas acquisitions became the foundation for long-term strategy despite regulatory headwinds?

The negotiations are expected to extend into late 2025 or early 2026. Regardless of the outcome, the story reflects a broader structural shift: blockchain is steadily moving into the infrastructure layer of China’s financial system.

Featured image via Shutterstock

Source: https://finbold.com/chinas-fintech-ambitions-drive-interest-in-venom-blockchain/

시장 기회
RealLink 로고
RealLink 가격(REAL)
$0.06732
$0.06732$0.06732
+1.55%
USD
RealLink (REAL) 실시간 가격 차트
면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, crypto.news@mexc.com으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.

USD1 Genesis: 0 Fees + 12% APR

USD1 Genesis: 0 Fees + 12% APRUSD1 Genesis: 0 Fees + 12% APR

New users: stake for up to 600% APR. Limited time!